MedKoo Cat#: 526936 | Name: WY-47766

Description:

WARNING: This product is for research use only, not for human or veterinary use.

WY-47766 is a proton pump inhibitor potentially for the treatment of postmenopausal osteoporosis.

Chemical Structure

WY-47766
WY-47766
CAS#134217-27-9

Theoretical Analysis

MedKoo Cat#: 526936

Name: WY-47766

CAS#: 134217-27-9

Chemical Formula: C14H13N3O2S

Exact Mass: 287.0728

Molecular Weight: 287.34

Elemental Analysis: C, 58.52; H, 4.56; N, 14.62; O, 11.14; S, 11.16

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
WY-47766; WY 47766; WY47766
IUPAC/Chemical Name
2-(3-Methoxybenzylsulfinyl)-3H-imidazo[4,5-c]pyridine
InChi Key
SWPJMIZLPONDGF-UHFFFAOYSA-N
InChi Code
InChI=1S/C14H13N3O2S/c1-19-11-4-2-3-10(7-11)9-20(18)14-16-12-5-6-15-8-13(12)17-14/h2-8H,9H2,1H3,(H,16,17)
SMILES Code
O=S(C(N1)=NC2=C1C=NC=C2)CC3=CC=CC(OC)=C3
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 287.34 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Major PP, Lipton A, Berenson J, Hortobagyi G. Oral bisphosphonates: A review of clinical use in patients with bone metastases. Cancer. 2000 Jan 1;88(1):6-14. Review. PubMed PMID: 10618600. 2: Morris SA, Shen H, Bex FJ, Bilezikian JP. Influence of antiresorptive agent OST-766 on signal transduction pathways involved in parathyroid hormone action. Calcif Tissue Int. 1999 Feb;64(2):148-53. PubMed PMID: 9914323. 3: Hall TJ, Schaueblin M. A pharmacological assessment of the mammalian osteoclast vacuolar H(+)-ATPase. Bone Miner. 1994 Nov;27(2):159-66. PubMed PMID: 7711523.